THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Monday reported second-quarter net income of $2.4 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Thousand Oaks, California-based company said it had net income of 19 cents.
The drug developer posted revenue of $17.6 million in the period.
Atara Biotherapeutics shares have fallen 22% since the beginning of the year. In the final minutes of trading on Monday, shares hit $10.32, a rise of 36% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA
/The%20sign%20for%20Marvell%20Technology%20out%20front%20of%20a%20corporate%20office%20by%20Valeriya%20Zankovych%20via%20Shutterstock.jpg)
/Microsoft%20Corporation%20logo%20on%20sign-by%20Jean-Luc%20Ichard%20via%20iStock.jpg)
/Palo%20Alto%20Networks%20Inc%20HQ%20sign-by%20Sundry%20Photography%20via%20Shutterstock.jpg)
